chromium has been researched along with Adenocarcinoma Of Kidney in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Azhdarpoor, A; Baghapour, MA; Hashemi, H; Radfard, M; Samaei, MR; Soleimani, H; Yunesian, M | 1 |
Bencko, V; Boffetta, P; Brennan, P; Chow, WH; Ferro, G; Fontana, L; Foretova, L; Janout, V; Jinga, V; Karami, S; Kollarova, H; Matveev, V; Moore, LE; Rothman, N; Stewart, P; Szeszenia-Dabrowska, N; van Bemmel, D; Zaridze, D | 1 |
Clarke, NW; Dangoor, A; Gilham, DE; Griffiths, RW; Hawkins, RE; Ramani, V; Stern, PL | 1 |
Eto, M; Harada, M; Ichikura, H; Naito, S; Takayama, K; Tatsugami, K; Tokuda, N; Ueno, H | 1 |
4 other study(ies) available for chromium and Adenocarcinoma Of Kidney
Article | Year |
---|---|
Prediction of human health risk and disability-adjusted life years induced by heavy metals exposure through drinking water in Fars Province, Iran.
Topics: Arsenic; Cadmium; Carcinogenesis; Carcinogens; Carcinoma, Renal Cell; Chromium; Disability-Adjusted Life Years; Drinking Water; Environmental Monitoring; Humans; Iran; Kidney Neoplasms; Lead; Metals, Heavy; Risk Assessment | 2023 |
Occupational exposure to arsenic, cadmium, chromium, lead and nickel, and renal cell carcinoma: a case-control study from Central and Eastern Europe.
Topics: Adult; Aged; Arsenic; Cadmium; Carcinoma, Renal Cell; Case-Control Studies; Chromium; Europe, Eastern; Female; Humans; Kidney Neoplasms; Lead; Male; Metals, Heavy; Middle Aged; Nickel; Occupational Diseases; Occupational Exposure; Risk Factors | 2011 |
Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antibodies, Monoclonal; Antigens, Neoplasm; Apoptosis; Carcinoma, Papillary; Carcinoma, Renal Cell; Chromium; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Immunotherapy; Interferon-gamma; Kidney Neoplasms; Male; Membrane Glycoproteins; Middle Aged; T-Lymphocytes | 2005 |
In vivo growth of transitional and renal cell carcinoma cell lines can be suppressed by the adenovirus-mediated expression of a soluble form of vascular endothelial growth factor receptor.
Topics: Adenoviridae; Animals; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Chromium; Gene Transfer Techniques; Genetic Therapy; Humans; Immunoglobulin Fc Fragments; Injections, Intramuscular; Injections, Subcutaneous; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Spleen; Survival Rate; T-Lymphocytes, Cytotoxic; Transfection; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2006 |